Randomized clinical trial: A double‐blind, proof‐of‐concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40 mg versus esomeprazole 40 mg in patients with symptomatic gastro‐esophageal reflux disease and partial response to a healing dose of a proton‐pump inhibitor-Reference-Cited by-同舟云学术

Randomized clinical trial: A double‐blind, proof‐of‐concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40 mg versus esomeprazole 40 mg in patients with symptomatic gastro‐esophageal reflux disease and partial response to a healing dose of a proton‐pump inhibitor

Published:2022-09-30 Issue:1 Volume:35 Page:
ISSN:1350-1925
Container-title:Neurogastroenterology & Motility
language:en
Short-container-title:Neurogastroenterology Motil

Author:

Tack Jan¹,Vladimirov Borislav²,Horny Ivo³,Chong Chui Fung⁴,Eisner Jessica⁵,Czerniak Richard⁶,Takanami Yohei⁶

Affiliation:

1. Department of Gastroenterology University Hospitals Leuven Leuven Belgium

2. Department of Gastroenterology University Hospital “Queen Giovanna‐ ISUL”, Medical University of Sofia Sofia Bulgaria

3. Department of Gastroenterology and Internal medicine Strakonice Hospital Czech Republic

4. Currently Hoffmann‐La Roche Formerly Takeda Development Center Asia Basel Switzerland

5. Formerly Takeda Pharmaceuticals International Co. Takeda Pharmaceuticals International Co. Cambridge USA

6. Takeda Pharmaceuticals International Co. Cambridge Massachusetts USA

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nmo.14468

Reference42 articles.

1. The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger?

2. Gastroesophageal Reflux Disease

3. Modern diagnosis of GERD: the Lyon Consensus

4. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review

5. Atypical presentations of gastroesophageal reflux disease;Heidelbaugh JJ;Am Fam Physician,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastroesophageal Reflux Disease;Annals of Internal Medicine;2024-08

2. Evaluating vonoprazan and tegoprazan for gastroesophageal reflux disease treatment in Chinese Healthcare: an EVIDEM framework analysis;BMC Gastroenterology;2024-06-20

3. Adjunctive Use of Wide-Area Transepithelial Sampling-3D in Patients With Symptomatic Gastroesophageal Reflux Increases Detection of Barrett's Esophagus and Dysplasia;American Journal of Gastroenterology;2024-04-18

4. Potassium-competitive acid blockers and acid-related disorders;Current Opinion in Endocrinology, Diabetes & Obesity;2024-03-14

5. Predicting pharmacodynamic effects through early drug discovery with artificial intelligence-physiologically based pharmacokinetic (AI-PBPK) modelling;Frontiers in Pharmacology;2024-02-16